172 related articles for article (PubMed ID: 15746600)
21. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
Ahmed AR; Colón JE
Arch Dermatol; 2001 Sep; 137(9):1181-9. PubMed ID: 11559214
[TBL] [Abstract][Full Text] [Related]
22. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
Li J; Kelly R
J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
[TBL] [Abstract][Full Text] [Related]
23. [Cicatricial pemphigoid, mucous membrane pemphigoid].
Doffoel-Hantz V; Robert PY; Bédane C
Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
[TBL] [Abstract][Full Text] [Related]
24. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
Ratnam KV
Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
[TBL] [Abstract][Full Text] [Related]
26. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
29. Ocular cicatricial pemphigoid.
Tauber J
Ophthalmology; 2008 Sep; 115(9):1639-40; author reply 1640-1. PubMed ID: 18762085
[No Abstract] [Full Text] [Related]
30. MMF and eye disease.
Zierhut M; Stübiger N; Siepmann K; Deuter CM
Lupus; 2005; 14 Suppl 1():s50-4. PubMed ID: 15803933
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients.
Wee JS; Shirlaw PJ; Challacombe SJ; Setterfield JF
Br J Dermatol; 2012 Jul; 167(1):36-43. PubMed ID: 22309851
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil for the management of autoimmune bullous diseases.
Eskin-Schwartz M; David M; Mimouni D
Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
[TBL] [Abstract][Full Text] [Related]
33. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
Kirtschig G; Murrell D; Wojnarowska F; Khumalo N
Arch Dermatol; 2002 Mar; 138(3):380-4. PubMed ID: 11902989
[TBL] [Abstract][Full Text] [Related]
34. Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
[TBL] [Abstract][Full Text] [Related]
35. Update on ocular cicatricial pemphigoid and emerging treatments.
Queisi MM; Zein M; Lamba N; Meese H; Foster CS
Surv Ophthalmol; 2016; 61(3):314-7. PubMed ID: 26708362
[TBL] [Abstract][Full Text] [Related]
36. Treatment of ocular cicatricial pemphigoid with sulfasalazine.
Doan S; Lerouic JF; Robin H; Prost C; Savoldelli M; Hoang-Xuan T
Ophthalmology; 2001 Sep; 108(9):1565-8. PubMed ID: 11535451
[TBL] [Abstract][Full Text] [Related]
37. [Mucous membrane pemphigoid: clinical manifestations and treatment with corticosteroids, dapsone and cyclophosphamide in 5 patients].
España A; del Olmo J; Marquina M; Fernández S; Panizo C; Maldonado M
Actas Dermosifiliogr; 2005; 96(6):357-64. PubMed ID: 16476254
[TBL] [Abstract][Full Text] [Related]
38. Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis.
Haubitz M; de Groot K
Clin Nephrol; 2002 Jun; 57(6):421-4. PubMed ID: 12078944
[TBL] [Abstract][Full Text] [Related]
39. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
[TBL] [Abstract][Full Text] [Related]
40. Clinical Approach to Ocular Cicatricial Pemphigoid.
Çiftçi MD; Korkmaz İ; Palamar M; Yaman B; Eğrilmez S; Yağcı A; Akalın T; Barut Selver Ö
Turk J Ophthalmol; 2023 Apr; 53(2):79-84. PubMed ID: 37089009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
